Physician profile
Patrick D Willis
NPI 1649317991
$2,988.69
in general payments reported to CMS, 2019-2025
13 companies · $1,617 in 2025
The $1,617 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $198 · 2021: $290 · 2022: $173 · 2023: $56.41 · 2024: $284 · 2025: $1,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,377 · Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,377.41 |
| Food and Beverage | $580.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $1,602.41 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $415.49 | 2019-2023 | Lifevest |
| Edwards Lifesciences Corporation | $331.71 | 2019-2024 | Sapien 3 Ultra Resilia |
| Abiomed | $134.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $130.67 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $99.00 | 2021 | |
| Cardiva Medical, INC. | $83.94 | 2022 | |
| Abbott Laboratories | $55.91 | 2019-2023 | Coroflow |
| E.R. Squibb & Sons, L.L.C. | $37.09 | 2023-2025 | Camzyos |
| Pfizer INC. | $36.25 | 2019 | |
| Medtronic Vascular, INC. | $24.90 | 2019 | |
| Teleflex LLC | $18.91 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.